Clinical Imaging Scientific Director – Oncology

Regeneron

. Own the strategy and execution of sophisticated early- and late-phase oncology imaging in clinical trials .

Posted 10/23/2026full-timeRemote • United StatesLead💰 $205,000 - $341,600 per yearWebsite

Core Competencies

Role fit

Core Competencies

Use this summary to align your resume positioning with the role.

Demonstrates extensive expertise in oncology imaging strategies and clinical trial execution, with a strong focus on developing imaging endpoints and biomarkers. Proven ability to lead regulatory interactions and manage complex stakeholder networks in clinical research.

Highest-signal resume keywords

Oncology Imaging ExperienceClinical Trial ManagementRegulatory Agency EngagementPET Imaging Biomarker DevelopmentImaging Endpoint Assessment

ATS Keywords

Tailor your resume

Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills

Clinical ImagingBiomarker DevelopmentRECIST 1.1 ImplementationIRECIST ImplementationPCWG3 ImplementationLugano Criteria ApplicationIMWG ApplicationQuantitative Imaging AnalysisStudy Scientific Director ExperienceMulti-Modality Imaging Design

Soft Skills

Superior Communication SkillsOrganizational SkillsProject LeadershipStakeholder ManagementChampioning Innovations

Certifications & Qualifications

PhD in Relevant Field

Industry Keywords

Oncology Drug DevelopmentClinical Imaging OperationsTumor Response AssessmentImaging ProtocolsStatistical Analysis Plans

About the role

Key responsibilities & impact

Own the strategy and execution of sophisticated early- and late-phase oncology imaging in clinical trials
Develop imaging endpoints and biomarkers and drive scientific imaging and tumor response assessment for oncology clinical studies
Create fit-for-purpose imaging biomarker strategies with research, clinical imaging and oncology therapeutic-area teams
Prepare and present clinical imaging strategies to senior management
Manage a complex network of stakeholders across Regeneron
Lead, design and implement multi-modality imaging measures as endpoints for oncology clinical studies
Collaborate with clinical teams as the imaging subject matter expert on imaging strategies, protocols, endpoints, manuals, charters, statistical analysis plans and clinical study reports
Work with Clinical Imaging Operations and imaging contract research organizations to ensure study imaging components and endpoint data integrity
Serve as Study Scientific Director for clinical trials qualifying and utilizing novel imaging biomarkers
Lead regulatory-agency interactions regarding imaging endpoints, procedures and biomarker development studies
Lead interactions with regulatory agencies and site ethics committees for approval of clinical imaging biomarker development studies

Requirements

What you’ll need

PhD program with a minimum of 10+ years of clinical imaging experience, including a minimum of 7 years within oncology drug development
Superior written and verbal communication and organization skills
Experience implementing central efficacy assessments using RECIST 1.1, iRECIST, PCWG3, Lugano and IMWG in oncology clinical trials
Successful engagement experience with regulatory agencies
Ability to champion imaging innovations and lead projects effectively
Experience as study scientific director of PET imaging biomarker clinical trials in Oncology
Experience applying PET imaging as a quantitative endpoint in clinical and preclinical studies in Oncology

Benefits

Comp & perks

Annual bonuses or other incentive plans
Equity awards
Pension or retirement benefits
401(k) company match
Health and wellness programs
Fitness centers
Medical, dental, vision, life and disability insurance benefits
Paid time off
Family support benefits
Reasonable accommodation during the recruitment process for applicants with known disabilities or chronic illnesses